Abstract
In a cross-sectional study, serum estradiol (E2) and sex hormone-binding globulin (SHBG) concentrations were not significantly related to age at menarche in premenopausal British women in the luteal or follicular phases of the cycle. In Japanese subjects in the luteal phase, a marginally higher concentration of E2 was observed in those who had undergone an early rather than a late menarche. In British women, previous oral contraceptive users had significantly lower luteal phase E2 concentrations than never users.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Kelsey JL: A review of the epidemiology of human breast cancer. Epidem Rev 1: 74–109, 1979
Hoel DG, Wakabayashi T, Pike MC: Secular trends in the distribution of breast cancer risk factors menarche, first birth, menopause, and weight in Hiroshima and Nagasaki, Japan. Am J Epidem 118: 78–89, 1983
Yuan JM, Yu MC, Ross RK, Gao YT, Henderson BE: Risk factors for breast cancer in Chinese women in Shanghai. Cancer Res 48: 1949–1953, 1988
Wang QS, Yu MC, Henderson BE: Risk factors for breast cancer in Tianjin, People's Republic of China. Natl Cancer Inst Monograph 69: 39–42, 1985
Key TJA, Pike MC: The role of oestrogens and progestagens in the epidemiology and prevention of breast cancer. Eur J Cancer Clin Oncol 24: 29–43, 1988
MacMahon B, Trichopoulos D, Brown J, Andersen AP, Cole P, De Waard F, Kauraniemi T, Polychronopoulou A, Ravnihar B, Stormby N, Westlund K: Age at menarche, urine estrogens, and breast cancer risk. Int J Cancer 30: 427–431, 1982
Vihko RK, Apter DL: The epidemiology and endocrinology of the menarche in relation to breast cancer. Cancer Surveys 5: 561–571, 1986
Vihko R, Apter D: Endogenous steroids in the pathophysiology of breast cancer. Crit Rev Oncol Haematol 9: 1–16, 1989
Apter D, Reinila M, Vihko R: Some endocrine characteristics of early menarche, a risk factor for breast cancer, are preserved into adulthood. Int J Cancer 44: 783–787, 1989
Moore JW, Key TJA, Bulbrook RD, Clark GMG, Allen DS, Wang DY, Pike MC: Sex hormone binding globulin and risk factors for breast cancer in a population of normal women who had never used exogenous hormones. Br J Cancer 56: 661–666, 1987
Ernster VL, Wrensch MR, Petrakis NL, King EB, Miike R, Murai J, Goodson WH, Siiteri PK: Benign and malignant breast disease: Initial study results of serum and breast fluid analyses of endogenous estrogens. JNCI 79: 949–960, 1987
Chen J, Campbell TC, Li J, Peto R: Diet, lifestyle, and mortality in China: A study of the characteristics of 65 Chinese counties. Oxford University Press, Oxford, 1990
Moore JW, Bulbrook RD: The epidemiology and function of sex hormone-binding globulin. In: Clarke JR (ed) Oxford Reviews of Reproductive Biology, vol 10. Oxford University Press, Oxford, 1988, pp 180–236
Key TJA, Pike MC, Moore JW, Bulbrook RD, Clark GMG, Allen DS, Wang DY: The relationships of SHBG with current and previous use of oral contraceptives and oestrogen replacement therapy. Contraception 39: 179–186, 1989
Cole P, Cramer D, Yen S, Paffenberger R, MacMahon B, Brown J: Estrogen profiles of premenopausal women with breast cancer. Cancer Res 38: 745–748, 1978
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Moore, J.W., Key, T.J.A., Wang, D.Y. et al. Blood concentrations of estradiol and sex hormone-binding globulin in relation to age at menarche in premenopausal British and Japanese women. Breast Cancer Res Tr 18 (Suppl 1), S47–S50 (1991). https://doi.org/10.1007/BF02633527
Issue Date:
DOI: https://doi.org/10.1007/BF02633527